CVSI — CV Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $6.77m
- $8.14m
- $13.79m
Annual cashflow statement for CV Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.6 | -8.21 | 3.1 | -2.39 | -0.958 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.11 | 1.83 | -5.08 | 0.756 | 0.826 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.9 | 3.56 | 4 | 0.458 | -0.47 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.49 | -1.89 | 2.25 | -0.861 | -0.407 |
| Capital Expenditures | -0.035 | 0 | — | -0.018 | -0.109 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.156 | -0.01 | 0 |
| Acquisition of Business | |||||
| Cash from Investing Activities | -0.035 | 0 | -0.156 | -0.028 | -0.109 |
| Financing Cash Flow Items | -0.229 | -0.615 | 0 | -0.005 | -0.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.37 | 1.12 | -1.39 | 0.032 | 0.337 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.15 | -0.764 | 0.706 | -0.863 | -0.176 |